March 3, 2017 / 12:16 PM / 6 months ago

BRIEF-Cytosorbents FY loss per share $0.47

March 3 (Reuters) - Cytosorbents Corp

* Cytosorbents reports record quarterly and full-year 2016 revenue

* Cytosorbents Corp - Q4 2016 product sales were $2.6 million representing a 75% increase over Q4 2015 sales

* Cytosorbents Corp - continue to expect Q1 2017 product sales to exceed sales reported in Q1 of 2016

* Cytosorbents Corp - believes that co has sufficient cash to fund its operations through first half of 2017

* Cytosorbents Corp - will need to raise additional capital to support its ongoing operations in future

* Cytosorbents Corp - will need to raise additional funds to support clinical trials in U.S. and in Europe

* Cytosorbents Corp - FY loss per share $0.47 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below